SCOTT M ROCKLAGE Insider Trading
Get free email notifications about insider trading for SCOTT M ROCKLAGE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SCOTT M ROCKLAGE. SCOTT M ROCKLAGE is a Director in CUBIST PHARMACEUTICALS INC ($CBST) and a Director in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and a Director in Pulmatrix, Inc. ($PULM) and a Director in Cidara Therapeutics, Inc. ($CDTX) and a in Aprea Therapeutics, Inc. ($APRE) and a Director in Aprea Therapeutics, Inc. ($APRE).
Address: 179 SANDY POND ROAD LINCOLN 01773 MA
Companies in which SCOTT M ROCKLAGE is an Insider
Aprea Therapeutics, Inc.
Trading Symbol: APREIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SCOTT M ROCKLAGE:
Holdings: 1,823,192 shares
Latest Transaction: Jul 01 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cidara Therapeutics, Inc.
Trading Symbol: CDTXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of SCOTT M ROCKLAGE: Director
Holdings: 50,412 shares
Current Value: $483,955
Latest Transaction: Jun 15 2018
$CDTX Market Capitalization: $167.56M
$CDTX Previous Close: $9.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CUBIST PHARMACEUTICALS INC
Trading Symbol: CBSTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SCOTT M ROCKLAGE: Director
Holdings: 166,448 shares
Latest Transaction: Dec 02 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
EPIRUS Biopharmaceuticals, Inc.
Trading Symbol: CRXXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SCOTT M ROCKLAGE: Director
Holdings: 0 shares
Latest Transaction: Jun 08 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Pulmatrix, Inc.
Trading Symbol: PULMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SCOTT M ROCKLAGE: Director
Holdings: 168,873 shares
Current Value: $830,855
Latest Transaction: Feb 25 2016
$PULM Market Capitalization: $73.21M
$PULM Previous Close: $4.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of SCOTT M ROCKLAGE
Sentiment: All, APRE, CDTX, CBST, CRXX, PULM
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 01 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | A | 38.78 | 5,600 | 217,168 | 5,600 | ||
Jun 18 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 33.30 | 4,807 | 160,073 | 75,965 | 80.8 K to 76 K (-5.95 %) |
Jun 18 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 33.30 | 115,357 | 3,841,388 | 1,823,192 | 1.9 M to 1.8 M (-5.95 %) |
Jun 15 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 28.75 | 9,800 | 281,776 | 80,772 | 90.6 K to 80.8 K (-10.82 %) |
Jun 15 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 28.75 | 235,200 | 6,762,635 | 1,938,549 | 2.2 M to 1.9 M (-10.82 %) |
May 21 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 35.15 | 10,200 | 358,530 | 90,572 | 100.8 K to 90.6 K (-10.12 %) |
May 21 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 35.15 | 244,800 | 8,604,720 | 2,173,748 | 2.4 M to 2.2 M (-10.12 %) |